Related Experiment Video
Updated: Aug 2, 2025

Monitoring eIF4F Assembly by Measuring eIF4E-eIF4G Interaction in Live Cells
Published on: May 1, 2020
Epigenetic Control of Translation Checkpoint and Tumor Progression via RUVBL1-EEF1A1 Axis
Mingli Li1, Lu Yang1,2, Anthony K N Chan1,2
1Department of Systems Biology, Beckman Research Institute, City of Hope Comprehensive Cancer Center, Duarte, CA, 91010, USA.
Abstract:
Epigenetic dysregulation is reported in multiple cancers including Ewing sarcoma (EwS). However, the epigenetic networks underlying the maintenance of oncogenic signaling and therapeutic response remain unclear. Using a series of epigenetics- and complex-focused CRISPR screens, RUVBL1, the ATPase component of NuA4 histone acetyltransferase complex, is identified to be essential for EwS tumor progression. Suppression of RUVBL1 leads to attenuated tumor growth, loss of histone H4 acetylation, and ablated MYC signaling. Mechanistically, RUVBL1 controls MYC chromatin binding and modulates the MYC-driven EEF1A1 expression and thus protein synthesis. High-density CRISPR gene body scan pinpoints the critical MYC interacting residue in RUVBL1. Finally, this study reveals the synergism between RUVBL1 suppression and pharmacological inhibition of MYC in EwS xenografts and patient-derived samples. These results indicate that the dynamic interplay between chromatin remodelers, oncogenic transcription factors, and protein translation machinery can provide novel opportunities for combination cancer therapy.
Insights
Researchers identified RUVBL1 as crucial for Ewing sarcoma progression by regulating MYC signaling and protein synthesis. Suppressing RUVBL1 shows promise for combination cancer therapy.
Area of Science:
- Oncology
- Epigenetics
- Molecular Biology
Background:
- Epigenetic dysregulation is implicated in various cancers, including Ewing sarcoma (EwS).
- The specific epigenetic mechanisms driving oncogenic signaling and treatment response in EwS are not fully understood.
Purpose of the Study:
- To elucidate the epigenetic networks essential for Ewing sarcoma tumor progression and therapeutic response.
- To identify key regulators of oncogenic signaling and protein synthesis in EwS.
Main Methods:
- Utilized epigenetics- and complex-focused CRISPR screens to identify essential genes in EwS.
- Performed CRISPR gene body scans to pinpoint critical functional residues.
- Investigated the effects of RUVBL1 suppression on MYC signaling, histone acetylation, and protein synthesis.
- Evaluated combination therapy strategies in EwS models.
Main Results:
- RUVBL1, a component of the NuA4 complex, was identified as essential for EwS tumor growth.
- RUVBL1 suppression led to reduced tumor growth, decreased histone H4 acetylation, and diminished MYC signaling.
- RUVBL1 was found to regulate MYC chromatin binding and MYC-driven EEF1A1 expression, impacting protein synthesis.
- Synergistic effects were observed between RUVBL1 suppression and MYC inhibition in EwS models.
Conclusions:
- RUVBL1 plays a critical role in maintaining oncogenic signaling and tumor progression in Ewing sarcoma.
- Targeting the interplay between chromatin remodelers, MYC, and protein translation offers a novel therapeutic strategy for EwS.
- Combination therapy involving RUVBL1 suppression and MYC inhibition demonstrates therapeutic potential for Ewing sarcoma.
Related Concept Videos
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Regulation of Expression Occurs at Multiple Steps
Transcription results in the generation of precursor (pre-mRNA) that consists of both exons and introns, which needs further processing before being translated to a...
Initiation of Translation
First, the initiator tRNA must be selected from the pool of elongator tRNAs by eukaryotic initiation factor 2 (eIF2). The initiator tRNA (Met-tRNAi) has conserved sequence elements including modified bases at...
Regulation of Expression at Multiple Steps
Epigenetic Regulation
X-chromosome...
Leaky Scanning

